India's main stock indexes hit record highs on Tuesday, following a rise in shares of companies such as airlines and hotels that are expected to benefit from a return to normalcy, as investors across the world cheered progress in the development of a coronavi…

Australian shares are poised to open sharply higher on Tuesday, tracking rallies in global equities, as investor risk appetite was boosted following promising developments toward a coronavirus vaccine.

Summary List Placement President Donald Trump and Vice President Mike Pence celebrated and appeared to take credit for Pfizer's COVID-19 vaccine success on Monday, though the federal government did not fund the vaccine's research and development.  Pfizer ann…

Trading volumes on retail platforms surged after the first successful data from a large-scale clinical trial of a coronavirus vaccine caused a stampede to buy up stocks.

Trading volumes on retail platforms surged after the first successful data from a large-scale clinical trial of a coronavirus vaccine caused a stampede to buy up stocks.

It turns out preventing Covid-19 is a bigger deal for markets and the global economy than the drawn-out election of a new U.S. president. News that a vaccine in the works from Pfizer and BioNTech may be over 90% effective gave stocks and government bond yield…

Shares of banks, oil and travel companies soared on Monday after Pfizer said its experimental COVID-19 vaccine was more than 90% effective, prompting investors to shift bets to beaten-down cyclical names from stay-at-home winners.

Shares of banks, oil and travel companies soared on Monday after Pfizer said its experimental COVID-19 vaccine was more than 90% effective, prompting investors to shift bets to beaten-down cyclical names from stay-at-home winners.

Canada's main stock index hit a two-month high on Monday after drugmaker Pfizer said its experimental COVID-19 vaccine was more than 90% effective and as hopes of more stimulus under U.S. President-elect Joe Biden also boosted sentiment.

Canada's main stock index hit a two-month high on Monday after drugmaker Pfizer said its experimental COVID-19 vaccine was more than 90% effective and as hopes of more stimulus under U.S. President-elect Joe Biden also boosted sentiment.

Summary List Placement

These are Business Insider's biggest healthcare stories for November 9.

President Donald Trump on Monday welcomed Pfizer Ic's experimental COVID-19 vaccine results, and the stock market boost it brought.

Shares in banks and in the travel and leisure industries surged 10% or more on Monday after Pfizer announced that its experimental COVID-19 vaccine was more than 90% effective, prompting a major rally in bourses across the world.

Pfizer Inc received informal requests relating to its operations in China from the U.S. Department of Justice and the U.S. Securities and Exchange Commission (SEC) in June and August, respectively, its regulatory filing https://bit.ly/38geoz2 showed o…

RT @Casey35375194: NEVER FORGET: TRUMP OWNS STOCK IN PFIZER/J&J WITH PFIZER AS THE BIGGEST MEDICAL DONOR TO TRUMP’S INAUGURATION https://t.…

RT @TheChiefNerd: “A former statistician at Pfizer and his associate have been charged (PDF) with insider trading, using advance informatio…

RT @TheoFleury14: She must’ve got some stock options in the divorce for Pfizer.

RT @TheoFleury14: She must’ve got some stock options in the divorce for Pfizer.

RT @TheoFleury14: She must’ve got some stock options in the divorce for Pfizer. https://t.co/pKXKJM7eve

RT @quad_canceled: @PressSec So.... Bidenomics equals what we have... it's garbage... the only people doing good are the ones who own Pfize…

RT @AlbaDocherty: Pfizer grossed 200B in 2022 but still can't keep needed drugs in stock due to "significant increases in demand". https:/…

Stock market is ruthless. After the biggest pandemic in 100 years and selling record number of vaccines, Pfizer is hovering near 2 year lows. RSI & MACD indicate divergence. Revenue still remains high. Looks like an opportunity for those who dare. DYOR. $NASDAQ $PFE $SPY https://t.co/ytKry3ihyc

RT @DvdndDiplomats: What dividend stock do you refuse to own? The hate for Pfizer $PFE in an earlier tweet has me interested in your othe…

RT @LetsGoBrando45: “That same week #BillGates, who was overseeing this simulation [Event 201], bought 1.1 Million shares of #BioNTech vacc…

RT @stillgray: Newsmax reports that Trump’s filings show has a ton of Pfizer and Johnson & Johnson stock. Suddenly his shilling for these c…

RT @DvdndDiplomats: What dividend stock do you refuse to own? The hate for Pfizer $PFE in an earlier tweet has me interested in your othe…

RT @getoffthefence1: Pfizer' stock has shed more than $80 billion in 2023! https://t.co/Wu2fJG4MTc

Pfizer' stock has shed more than $80 billion in 2023! https://t.co/Wu2fJG4MTc

RT @DvdndDiplomats: What dividend stock do you refuse to own? The hate for Pfizer $PFE in an earlier tweet has me interested in your othe…

RT @erica4ou: We always talk about Pfizer, but how many got mega rich off Moderna? Moderna stock went from: $19 in January 2020 to $449…

RT @KanekoaTheGreat: 30/ The @CCCAlliance alleged that 84% of the Pfizer report authors had a conflict of interest. They were either emplo…

RT @AlbaDocherty: Pfizer grossed 200B in 2022 but still can't keep needed drugs in stock due to "significant increases in demand". https:/…

RT @AlbaDocherty: Pfizer grossed 200B in 2022 but still can't keep needed drugs in stock due to "significant increases in demand". https:/…

RT @AlbaDocherty: Pfizer grossed 200B in 2022 but still can't keep needed drugs in stock due to "significant increases in demand". https:/…

RT @AlbaDocherty: Pfizer grossed 200B in 2022 but still can't keep needed drugs in stock due to "significant increases in demand". https:/…

Pfizer grossed 200B in 2022 but still can't keep needed drugs in stock due to "significant increases in demand". https://t.co/pcuI9XqMmy

RT @KanekoaTheGreat: 30/ The @CCCAlliance alleged that 84% of the Pfizer report authors had a conflict of interest. They were either emplo…

RT @mrvegas95214342: Pfizer stock DOWN 30% since Jan 1. Getting ready for the lawsuits.